Filed: 2/14/2023ACC: 0001214659-23-002379
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 32 equity positions with a total reported market value of $642.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
32
Positions
$642.22M
Total AUM (reported)
31.54M
Total Shares
Allocation by class
COM$492.28M76.7%
SPONSORED ADS$64.49M10.0%
COM NEW$55.28M8.6%
S&P BIOTECH$16.55M2.6%
CL A$12.87M2.0%
SPON ADS$750.0K0.1%
Portfolio Concentration
Top 3$294.75M45.9%
4–10$210.26M32.7%
11–25$128.68M20.0%
Rest$8.53M1.3%
Top 3 weight
45.9%
Top 10 weight
78.6%
Voting Authority Distribution
Total shares with voting rights: 31.54M
Sole
Full voting authority
31.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole32
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings32
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.16M
TypeSH
Market value$163.40M
25.44%
Sole
3.16M
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares2.55M
TypeSH
Market value$66.85M
10.41%
Sole
2.55M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares2.47M
TypeSH
Market value$64.49M
10.04%
Sole
2.47M
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares2.48M
TypeSH
Market value$51.34M
7.99%
Sole
2.48M
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$33.98M
5.29%
Sole
750K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares761.40K
TypeSH
Market value$33.94M
5.28%
Sole
761.40K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares1.28M
TypeSH
Market value$27.36M
4.26%
Sole
1.28M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares824.20K
TypeSH
Market value$24.07M
3.75%
Sole
824.20K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares474.93K
TypeSH
Market value$21.35M
3.32%
Sole
474.93K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares621.71K
TypeSH
Market value$18.22M
2.84%
Sole
621.71K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares199.42K
TypeSH
Market value$16.55M
2.58%
Sole
199.42K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares665.16K
TypeSH
Market value$12.87M
2.00%
Sole
665.16K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares220.95K
TypeSH
Market value$11.69M
1.82%
Sole
220.95K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.86M
TypeSH
Market value$11.66M
1.82%
Sole
1.86M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares500K
TypeSH
Market value$11.10M
1.73%
Sole
500K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares1.23M
TypeSH
Market value$9.00M
1.40%
Sole
1.23M
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares445K
TypeSH
Market value$8.69M
1.35%
Sole
445K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares870.50K
TypeSH
Market value$8.18M
1.27%
Sole
870.50K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares324.63K
TypeSH
Market value$7.20M
1.12%
Sole
324.63K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares933.74K
TypeSH
Market value$7.12M
1.11%
Sole
933.74K
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares763.46K
TypeSH
Market value$7.05M
1.10%
Sole
763.46K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares2.42M
TypeSH
Market value$6.52M
1.02%
Sole
2.42M
Shared
0.00
None
0.00
89BIO INC
SOLEShares380K
TypeSH
Market value$4.84M
0.75%
Sole
380K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares1.96M
TypeSH
Market value$4.25M
0.66%
Sole
1.96M
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$1.95M
0.30%
Sole
100K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.16M | SH | $163.40M 25.44% | 3.16M | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 2.55M | SH | $66.85M 10.41% | 2.55M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 2.47M | SH | $64.49M 10.04% | 2.47M | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 2.48M | SH | $51.34M 7.99% | 2.48M | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 750K | SH | $33.98M 5.29% | 750K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 761.40K | SH | $33.94M 5.28% | 761.40K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 1.28M | SH | $27.36M 4.26% | 1.28M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 824.20K | SH | $24.07M 3.75% | 824.20K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 474.93K | SH | $21.35M 3.32% | 474.93K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 621.71K | SH | $18.22M 2.84% | 621.71K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 199.42K | SH | $16.55M 2.58% | 199.42K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 665.16K | SH | $12.87M 2.00% | 665.16K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 220.95K | SH | $11.69M 1.82% | 220.95K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.86M | SH | $11.66M 1.82% | 1.86M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 500K | SH | $11.10M 1.73% | 500K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 1.23M | SH | $9.00M 1.40% | 1.23M | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 445K | SH | $8.69M 1.35% | 445K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 870.50K | SH | $8.18M 1.27% | 870.50K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 324.63K | SH | $7.20M 1.12% | 324.63K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 933.74K | SH | $7.12M 1.11% | 933.74K | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 763.46K | SH | $7.05M 1.10% | 763.46K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 2.42M | SH | $6.52M 1.02% | 2.42M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 380K | SH | $4.84M 0.75% | 380K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 1.96M | SH | $4.25M 0.66% | 1.96M | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 100K | SH | $1.95M 0.30% | 100K | 0.00 | 0.00 |
Page 1 of 2